University of Minnesota
University of Minnesota
Minneapolis, Minnesota, United States325 results · Page 1 of 13
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Diagnosing Epilepsy To EffeCT Change | brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Recruiting | Not applicable | 2026-10-09 | NCT07110337 | |
| Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension | cardiovascular disorder, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not applicable | 2026-10-09 | NCT06911632 | |
| Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, ovarian germ cell tumor, testicular cancer, testicular disorder, testicular germ cell tumor, uterine disorder | Recruiting | Phase 1 | 2026-10-09 | NCT06276491 | |
| A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder | Active, not recruiting | Phase 3 | 2026-10-09 | NCT05444257 | |
| Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant | Bacterial Infections and Mycoses, Enterobacteriaceae Infections, Infections, bacterial infectious disease, escherichia coli infection, gram-negative bacterial infections | Recruiting | Phase 1 / Phase 2 | 2026-10-08 | NCT06938867 | |
| CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients | CMV; Kidney Transplant; Complications | Recruiting | Phase 1 / Phase 2 | 2026-10-07 | NCT07096453 | |
| Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, acute myeloid leukemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 3 | 2026-10-07 | NCT07007312 | |
| Health Outcomes of Parents With Cystic Fibrosis-Aim 2 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder | Recruiting | Not stated | 2026-10-07 | NCT06296394 | |
| SERENITY Study of Chronic Pain Interference in Adults | Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, central nervous system disorder, injury, nervous system disorder, nervous system injury, neuralgia, neuromuscular disease, peripheral nervous system disorder, spinal cord disorder, spinal cord injury | Not yet recruiting | Not stated | 2026-10-06 | NCT07820475 | |
| Microbiome-targeted Diet Therapy in Ulcerative Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Not applicable | 2026-10-06 | NCT07520461 | |
| Phase 2 Study to Assess the Safety and Efficacy of ANG003 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, exocrine pancreatic insufficiency, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder | Recruiting | Phase 2 | 2026-10-06 | NCT07450547 | |
| A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 2 | 2026-10-06 | NCT07223697 | |
| Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib | Skin and Connective Tissue Diseases, alopecia, alopecia areata, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Active, not recruiting | Not stated | 2026-10-06 | NCT06531109 | |
| Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease | idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Enrolling by invitation | Phase 3 | 2026-10-06 | NCT04905693 | |
| VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS) | Ascites, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, liver disorder, portal hypertension | Recruiting | Not stated | 2026-10-05 | NCT07390344 | |
| A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy | Symptomatic Genetic Dilated Cardiomyopathy | Recruiting | Phase 2 / Phase 3 | 2026-10-05 | NCT07210723 | |
| A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis | Fibrosis, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, hypersensitivity pneumonitis, immune system disorder, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Active, not recruiting | Phase 2 | 2026-10-05 | NCT06329401 | |
| LMN-201 for Prevention of C. Difficile Infection Recurrence | Bacterial Infections and Mycoses, Clostridium difficile Infections, Clostridium infectious disease, Infections, bacterial infectious disease, gram-positive bacterial infections | Active, not recruiting | Phase 2 / Phase 3 | 2026-10-05 | NCT05330182 | |
| Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1 | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizoaffective disorder, schizophrenia | Recruiting | Not applicable | 2026-10-02 | NCT07853807 | |
| A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy | Symptomatic Genetic Dilated Cardiomyopathy (DCM) | Recruiting | Phase 3 | 2026-10-02 | NCT07771465 | |
| Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (Histo-FACT) | Bacterial Infections and Mycoses, Infections, fungal infectious disease, histoplasmosis | Not yet recruiting | Phase 3 | 2026-10-02 | NCT07261150 | |
| R01_Pilot Jaw Muscle Phenotypes | Craniomandibular Disorders, Jaw Diseases, Mandibular Diseases, Stomatognathic Diseases, arthropathy, muscle tissue disorder, musculoskeletal system disorder, temporomandibular joint disorder | Not yet recruiting | Not applicable | 2026-10-02 | NCT07153107 | |
| A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases | interstitial lung disease, lung disorder, respiratory system disorder | Active, not recruiting | Phase 3 | 2026-10-02 | NCT06806592 | |
| Effect of Vagal Nerve Stimulation on Gastric Motor Functions | brain disorder, central nervous system disorder, depressive disorder, epilepsy, nervous system disorder | Recruiting | Not applicable | 2026-10-02 | NCT06038929 | |
| Evaluation of the SCALED (SCaling AcceptabLE cDs) | Brain Injuries, Traumatic, Craniocerebral Trauma, Embolism and Thrombosis, Thromboembolism, brain disorder, brain injury, cardiovascular disorder, central nervous system disorder, injury, nervous system disorder, nervous system injury, vascular disorder, venous thromboembolism | Active, not recruiting | Not stated | 2026-10-02 | NCT05628207 |